Mariela M. García-Zendejas, Servicio de Urgencias, Hospital General Salvador Zubirán Anchondo, Chihuahua, Chihuahua, México
Edgar A. Cano-Torres, Department of Internal Medicine, Hospital Rebren, Durango, Durango, México
Luis E. Simental-Mendía, Unidad de Investigación Biomédica, Delegación Durango, Instituto Mexicano del Seguro Social, Durango, Durango, México
Objective: The study aimed to determine the association between serum magnesium and Vitamin D levels with the severity and mortality by coronavirus disease 19 (COVID-19) in hospitalized patients. Method: Men and women over 18 years of age with probable COVID-19 were enrolled in a case–control study. Patients with a positive or negative test for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were allocated into case or control groups, respectively. Vitamin D deficiency was defined by concentrations < 20 ng/mL and hypomagnesemia by serum levels < 1.8 mg/dL. Results: A total of 54 patients, 30 women and 24 men, were enrolled and allocated into the groups with (n = 27) and without (n = 27) COVID-19. The logistic regression analysis showed that Vitamin D deficiency (odds ratio [OR] = 6.13; 95% confidence intervals [CI]: 1.32- 28.34) and insufficiency (OR = 0.12; 95% CI: 0.02-0.60) are significantly associated with hospitalization. However, Vitamin D disorders and hypomagnesemia were not associated with mortality. Conclusions: The results of the present study revealed that Vitamin D disturbances, but not hypomagnesemia, are associated with the severity of SARS-CoV-2.
Keywords: Coronavirus disease 19. Magnesium. Mortality. Severity. Vitamin D.